Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | CDC20 | Cell division cycle protein 20 homolog | Q12834 | | wr7 | Crystal structure of Cdc20 and apcin complex | 4n14 | 65.62 | | no data |
2 | EED | Polycomb protein EED | O75530 | | l9w | EED in complex with a methyl-thiazole | 6sfc | 75.6 | | no data |
3 | EED | Polycomb protein EED | O75530 | | l9k | EED in complex with a triazolopyrimidine | 6sfb | 74.55 | | no data |
4 | EED | Polycomb protein EED | O75530 | | 82g | Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine | 5u8f | 77.06 | | 11. |
5 | EED | Polycomb protein EED | O75530 | | 73k | Crystal structure of EED [G255D] in complex with EZH2 peptide and EED226 compound | 5wuk | 72.42 | | 14. |
6 | EED | Polycomb protein EED | O75530 | | 73k | EED in complex with an allosteric PRC2 inhibitor | 5gsa | 74.11 | | 82. |
7 | EED | Polycomb protein EED | O75530 | | lqe | EED in complex with PRC2 allosteric inhibitor EED210 | 5h17 | 75.48 | | 890. |
8 | EED | Polycomb protein EED | O75530 | | lqf | EED in complex with PRC2 allosteric inhibitor EED162 | 5h19 | 76.01 | | 320. |
9 | EED | Polycomb protein EED | O75530 | | 6pu | Targeting the PRC2 complex through a novel protein-protein interaction inhibitor of EED | 5k0m | 69.52 | | no data |
10 | EED | Polycomb protein EED | O75530 | | lqd | EED in complex with PRC2 allosteric inhibitor EED709 | 5h15 | 76.45 | | 1570. |
11 | EED | Polycomb protein EED | O75530 | | lqd | Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(2-methoxyphenyl)methyl]-N,N-dimethyl-4-(1-methylindol-3-yl)pyrrolidin-3-amine | 5u69 | 78.24 | | 600. |
12 | EED | Polycomb protein EED | O75530 | | 7xg | Polycomb protein EED in complex with inhibitor: 2-[4-(4-{(3S,4R)-4-(dimethylamino)-1-[(2-fluoro-6-methylphenyl)methyl]pyrrolidin-3-yl}phenyl)-1H-pyrazol-1-yl]acetamide | 5u6d | 70.67 | | 2.6 |
13 | EED | Polycomb protein EED | O75530 | | 82d | Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(2-bromo-6-fluorophenyl)methyl]-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine | 5u8a | 77.86 | | 13. |
14 | EED | Polycomb protein EED | O75530 | | 7wd | Crystal structure of EED in complex with H3K27Me3 peptide and 6-(benzo[d][1,3]dioxol-4-ylmethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-3-amine | 5u62 | 87.23 | | 1300. |
15 | EED | Polycomb protein EED | O75530 | | 7w7 | Crystal structure of EED in complex with H3K27Me3 peptide and 3-(benzo[d][1,3]dioxol-4-ylmethyl)piperidine-1-carboximidamide | 5u5t | 88.42 | | 3900. |
16 | EED | Polycomb protein EED | O75530 | | 7vv | Crystal structure of EED in complex with 6-(2-fluoro-5-methoxybenzyl)-1-isopropyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-3-amine 6-(2-fluoro-5-methoxybenzyl)-1-isopropyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-3-amine | 5u5h | 77.44 | | 1300. |
17 | FBW1A | F-box/WD repeat-containing protein 1A | Q9Y297 | BTRCP FBW1A FBXW1A | j91 | Monophosphorylated pSer33 b-Catenin peptide, b-TrCP/Skp1, NRX-2776 ternary complex | 6m90 | 65.78 | | no data |
18 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | hls | Displacement of WDR5 from chromatin by a pharmacological WIN site inhibitor with picomolar affinity | 6e22 | 74.97 | | no data |
19 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | hlm | Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design | 6e1y | 82.26 | | no data |
20 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | hlj | Displacement of WDR5 from chromatin by a pharmacological WIN site inhibitor with picomolar affinity | 6e23 | 86.06 | | no data |
21 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | hhm | WDR5 in complex with a WIN site inhibitor | 6dya | 76.55 | | no data |
22 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | hh7 | WDR5 in complex with a WIN site inhibitor | 6dy7 | 81.13 | | no data |
23 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | g2j | Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design | 6dar | 75.76 | | no data |
24 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | g2d | Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design | 6das | 81.78 | | no data |
25 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | 5mo | Crystal structure of human WDR5 in complex with compound 9e | 5eap | 87.54 | | no data |
26 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | 5ml | Crystal structure of human WDR5 in complex with compound 9h | 5eal | 84.04 | | no data |
27 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | 35q | Crystal structure of human WDR5 in complex with compound OICR-9429 | 4ql1 | 71.99 | | 93. |
28 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | np7 | Crystal structure of human WD repeat domain 5 with compound | 3smr | 84.74 | | no data |
29 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | 0bw | Crystal structure of human WD repeat domain 5 with compound | 3ur4 | 88.05 | | no data |
30 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | ia9 | Crystal structure of human WD REPEAT DOMAIN 5 in complex with 2-chloro-4-fluoro-3-methyl-N-[2-(4-methylpiperazin-1-yl)-5-nitrophenyl]benzamide | 4ia9 | 90 | | no data |
31 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | 5mq | Crystal structure of human WDR5 in complex with compound 9d | 5ear | 84.46 | | no data |
32 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | g2v | Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design | 6dai | 88.31 | | no data |
33 | WDR5 | WD repeat-containing protein 5 | P61964 | BIG3 | g1y | Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design | 6dak | 77.46 | | no data |